[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610502":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":20,"responsibleParty":30,"collaborators":20,"id":32,"slug":20,"hasResults":33,"nctId":34,"briefTitle":35,"officialTitle":36,"acronym":20,"eligibilityCriteria":37,"healthyVolunteers":38,"sex":39,"minAge":40,"maxAge":20,"enrollmentInfo":41,"targetDuration":20,"studyType":44,"phases":45,"briefSummary":47,"conditions":48,"keywords":50,"overallStatus":52,"whyStopped":20,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":20},{"fullName":5,"class":6},"ivWatch, LLC","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Non-Infiltrated Tissue","EXPERIMENTAL","The ivWatch Model 400 monitored a common peripheral IV site over a 24 hour observation period.",[13],"Device: ivWatch Model 400",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","ivWatch Model 400","The ivWatch Model 400 monitored tissue at common IV sites over a 24 hour period.",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Jason Naramore CTO, MS","CONTACT","(855) 489-2824","jason.naramore@ivwatch.com",{"name":28,"role":24,"phone":25,"phoneExt":20,"email":29},"Marisa Brown, BS","marisa.brown@ivwatch.com",{"type":31,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100610502",false,"NCT07228416","Milky Way Sensor Motion Validation","Milky Way Sensor: Device Validation for Non-Infiltrated Tissues","Inclusion Criteria:\n\n* 18 years of age or older\n* Healthy individual, verified by an eligible designation on the Health History Form\n\nExclusion Criteria:\n\n* Currently enrolled in another clinical trial\n* Currently pregnant or trying to become pregnant\n* Serious and uncontrolled medical condition\n* Tattoo(s), scarring, or bruising that severely limits vein visualization at a sensor monitoring location\n* Medical adhesive allergy\n* Sleepwalking occurrence in the last year\n* Current drug\u002Falcohol dependence\n* Sick or had an infection in the last 14 days\n* Hospitalized in the last 14 days\n* Fever at the time of study visit (≥100.4°F)",true,"ALL","18 Years",{"count":42,"type":43},25,"ESTIMATED","INTERVENTIONAL",[46],"NA","A single arm study of 20 adult volunteers to assess the safety and efficacy of the ivWatch sensors when observing non-infiltrated (normal) tissues at common peripheral IV therapy sites.",[49],"Infiltration of Peripheral IV Therapy",[51],"motion","NOT_YET_RECRUITING","2025-11-13",{"date":55,"type":56},"2025-11-14","ACTUAL",{"date":58,"type":43},"2025-12",{"date":60,"type":43},"2026-01",{"name":5,"class":6}]